Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.
Miró
E
E
Navarro
F
F
March
F
F
Sanchez
F
F
Mirelis
B
B
D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D012772:Shock, Septic / Q000188:drug therapy*; D013845:Thienamycins / Q000627:therapeutic use*; D018440:beta-Lactam Resistance
D000890:Anti-Infective Agents; D013845:Thienamycins; D002939:Ciprofloxacin; D015378:Imipenem